Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Zinn, P. Sathyan, Bhanu Mahajan, J. Bruyere, M. Hegi, S. Majumder, R. Colen (2012)
A Novel Volume-Age-KPS (VAK) Glioblastoma Classification Identifies a Prognostic Cognate microRNA-Gene SignaturePLoS ONE, 7
C. Belden, P. Valdes, C. Ran, D. Pastel, B. Harris, C. Fadul, M. Israel, K. Paulsen, D. Roberts (2011)
Genetics of glioblastoma: a window into its imaging and histopathologic variability.Radiographics : a review publication of the Radiological Society of North America, Inc, 31 6
R. McLendon, A. Friedman, D. Bigner, Erwin Meir, D. Brat, Gena Mastrogianakis, J. Olson, T. Mikkelsen, N. Lehman, K. Aldape, W. Yung, O. Bogler, J. Weinstein, S. Vandenberg, M. Berger, M. Prados, D. Muzny, M. Morgan, S. Scherer, A. Sabo, L. Nazareth, L. Lewis, O. Hall, Yiming Zhu, Yanru Ren, Omar Alvi, Jiqiang Yao, A. Hawes, S. Jhangiani, G. Fowler, A. Lucas, C. Kovar, Andrew Cree, H. Dinh, J. Santibanez, Vandita Joshi, M. Gonzalez-Garay, Christopher Miller, A. Milosavljevic, L. Donehower, D. Wheeler, R. Gibbs, K. Cibulskis, C. Sougnez, T. Fennell, Scott Mahan, Jane Wilkinson, L. Ziaugra, R. Onofrio, Toby Bloom, R. Nicol, K. Ardlie, J. Baldwin, S. Gabriel, E. Lander, L. Ding, R. Fulton, M. McLellan, J. Wallis, D. Larson, Xiaoqi Shi, R. Abbott, L. Fulton, Ken Chen, D. Koboldt, M. Wendl, R. Meyer, Yuzhu Tang, Ling Lin, John Osborne, Brian Dunford-Shore, T. Miner, K. Delehaunty, C. Markovic, Gary Swift, W. Courtney, C. Pohl, S. Abbott, Amy Hawkins, Shin Leong, C. Haipek, Heather Schmidt, M. Wiechert, T. Vickery, S. Scott, D. Dooling, A. Chinwalla, G. Weinstock, E. Mardis, R. Wilson, G. Getz, W. Winckler, R. Verhaak, M. Lawrence, Michael O’Kelly, James Robinson, Gabriele Alexe, R. Beroukhim, S. Carter, Derek Chiang, Josh Gould, Supriya Gupta, Joshua Korn, C. Mermel, J. Mesirov, S. Monti, Huy Nguyen, Melissa Parkin, Michael Reich, Nicolas Stransky, B. Weir, L. Garraway, T. Golub, M. Meyerson, L. Chin, A. Protopopov, Jianhua Zhang, I. Perna, S. Aronson, N. Sathiamoorthy, Georgi Ren, Jun Yao, W. Wiedemeyer, Hyun Kim, Won Sek, Yonghong Xiao, I. Kohane, J. Seidman, P. Park, R. Kucherlapati, P. Laird, L. Cope, J. Herman, D. Weisenberger, F. Pan, D. Berg, L. Neste, Mingyu Joo, Kornel Schuebel, S. Baylin, D. Absher, Jun Li, Audrey Southwick, Shannon Brady, A. Aggarwal, Tisha Chung, G. Sherlock, J. Brooks, R. Myers, P. Spellman, E. Purdom, L. Jakkula, A. Lapuk, H. Marr, S. Dorton, Gi Yoon, Ju Han, A. Ray, V. Wang, S. Durinck, M. Robinson, Nicholas Wang, K. Vranizan, V. Peng, E. Name, G. Fontenay, J. Ngai, J. Conboy, B. Parvin, H. Feiler, T. Speed, J. Gray, C. Brennan, N. Socci, A. Olshen, B. Taylor, A. Lash, N. Schultz, B. Reva, Yevgeniy Antipin, Alexey Stukalov, Benjamin Gross, E. Cerami, Qingqing Wei, L. Qin, V. Seshan, Liliana Villafania, Magali Cavatore, L. Borsu, A. Viale, W. Gerald, C. Sander, M. Ladanyi, C. Perou, D. Hayes, M. Topal, K. Hoadley, Yuan Qi, S. Balu, Yan Shi, Junyuan Wu, R. Penny, M. Bittner, T. Shelton, E. Lenkiewicz, S. Morris, D. Beasley, Sheri Sanders, A. Kahn, R. Sfeir, Jessica Chen, D. Nassau, Larry Feng, E. Hickey, A. Barker, D. Gerhard, J. Vockley, C. Compton, J. Vaught, P. Fielding, M. Ferguson, C. Schaefer, Jinghui Zhang, Subha Madhavan, K. Buetow, F. Collins, P. Good, M. Guyer, B. Ozenberger, Jane Peterson, E. Thomson (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 455
JA Carrillo, A Lai, PL Nghiemphu (2012)
Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastomaAJNR Am J Neuroradiol, 33
O. Gevaert, L. Mitchell, A. Achrol, Jiajing Xu, Sebastian Echegaray, G. Steinberg, S. Cheshier, S. Napel, G. Zaharchuk, S. Plevritis (2014)
Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.Radiology, 273 1
S. Nobusawa, Takuya Watanabe, P. Kleihues, H. Ohgaki (2009)
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary GlioblastomasClinical Cancer Research, 15
Hai Yan, D. Parsons, Geng-lin Jin, R. McLendon, B. Rasheed, Weishi Yuan, I. Kos, I. Batinic-Haberle, Siân Jones, G. Riggins, H. Friedman, A. Friedman, D. Reardon, J. Herndon, Kenneth Kinzler, V. Velculescu, B. Vogelstein, D. Bigner (2009)
IDH1 and IDH2 mutations in gliomas.The New England journal of medicine, 360 8
S. Higano, Xia Yun, T. Kumabe, Mika Watanabe, S. Mugikura, A. Umetsu, A. Sato, Takayuki Yamada, Shoki Takahashi (2006)
Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis.Radiology, 241 3
R. Stupp, Warren Mason, M. Bent, M. Weller, B. Fisher, M. Taphoorn, K. Bélanger, A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, Robert Janzer, Samuel Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J. Cairncross, E. Eisenhauer, R. Mirimanoff (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.The New England journal of medicine, 352 10
Y. Jiao, Patrick Killela, Zachary Reitman, A. Rasheed, C. Heaphy, R. Wilde, F. Rodriguez, S. Rosemberg, S. Oba-Shinjo, S. Marie, C. Bettegowda, N. Agrawal, E. Lipp, Christopher Pirozzi, G. López, Yiping He, H. Friedman, A. Friedman, G. Riggins, M. Holdhoff, P. Burger, R. McLendon, D. Bigner, B. Vogelstein, A. Meeker, K. Kinzler, N. Papadopoulos, L. Diaz, Hai Yan (2012)
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomasOncotarget, 3
N. Jamshidi, M. Diehn, M. Bredel, M. Kuo (2013)
Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation.Radiology, 270 1
P. Zinn, R. Colen (2013)
Imaging genomic mapping in glioblastoma.Neurosurgery, 60 Suppl 1
D. Gutman, L. Cooper, Scott Hwang, C. Holder, Jingjing Gao, Tarun Aurora, William Dunn, L. Scarpace, T. Mikkelsen, R. Jain, M. Wintermark, Manal Jilwan, P. Raghavan, Erich Huang, R. Clifford, P. Mongkolwat, Vladimir Kleper, J. Freymann, J. Kirby, P. Zinn, C. Moreno, C. Jaffe, R. Colen, D. Rubin, J. Saltz, A. Flanders, D. Brat (2013)
MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set.Radiology, 267 2
Jose Carrillo, A. Lai, P. Nghiemphu, Hyun Kim, Heidi Phillips, Samir Kharbanda, P. Moftakhar, S. Lalaezari, William Yong, B. Ellingson, T. Cloughesy, W. Pope (2012)
Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, MGMT Promoter Methylation, and Survival in GlioblastomaAmerican Journal of Neuroradiology, 33
B. Joe, M. Fukui, C. Meltzer, Q. Huang, R. Day, Phil Greer, M. Bozik (1999)
Brain tumor volume measurement: comparison of manual and semiautomated methods.Radiology, 212 3
V. Frattini, V. Trifonov, Joseph Chan, Angelica Castano, M. Lia, F. Abate, S. Keir, A. Ji, P. Zoppoli, F. Niola, Carla Danussi, Igor Dolgalev, Paola Porrati, S. Pellegatta, A. Heguy, Gaurav Gupta, D. Pisapia, P. Canoll, J. Bruce, R. McLendon, Hai Yan, K. Aldape, G. Finocchiaro, T. Mikkelsen, G. Privé, D. Bigner, A. Lasorella, R. Rabadán, A. Iavarone (2013)
The integrated landscape of driver genomic alterations in glioblastomaNature genetics, 45
Charles Hill, S. Hunter, D. Brat (2003)
Genetic Markers in Glioblastoma: Prognostic Significance and Future Therapeutic Implications: On: Impact of Genotype Morphology on the Prognosis of Glioblastoma. Schmidt MC Antweiler S, Urban N, et al. J Neuropathol Exp Neurol 2002;61:321–328.Advances in Anatomic Pathology, 10
Zhen Xing, Xiefeng Yang, D. She, Yuanxiang Lin, Yuyang Zhang, D. Cao (2017)
Noninvasive Assessment of IDH Mutational Status in World Health Organization Grade II and III Astrocytomas Using DWI and DSC-PWI Combined with Conventional MR ImagingAmerican Journal of Neuroradiology, 38
Krishanthan Vigneswaran, S. Neill, C. Hadjipanayis (2015)
Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification.Annals of translational medicine, 3 7
K Aldape (2007)
242Arch Pathol Lab Med, 131
D. Louis, A. Perry, G. Reifenberger, A. Deimling, D. Figarella-Branger, W. Cavenee, H. Ohgaki, O. Wiestler, P. Kleihues, D. Ellison (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 131
B. Wiestler, D. Capper, T. Holland-Letz, A. Korshunov, A. Deimling, S. Pfister, M. Platten, M. Weller, W. Wick (2013)
ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosisActa Neuropathologica, 126
K. Büsing, A. Kilian, T. Schaible, A. Debus, C. Weiss, K. Neff (2008)
Reliability and validity of MR image lung volume measurement in fetuses with congenital diaphragmatic hernia and in vitro lung models.Radiology, 246 2
John, H., Rees, James, G., Smirniotopoulos, Robert, V. Jones (1996)
Glioblastoma multiforme: radiologic-pathologic correlation.Radiographics : a review publication of the Radiological Society of North America, Inc, 16 6
R. Verhaak, K. Hoadley, E. Purdom, V. Wang, Y. Qi, M. Wilkerson, C. Miller, L. Ding, Todd Golub, J. Mesirov, Gabriele Alexe, M. Lawrence, Michael O’Kelly, P. Tamayo, B. Weir, S. Gabriel, W. Winckler, Supriya Gupta, L. Jakkula, H. Feiler, J. Hodgson, C. James, J. Sarkaria, C. Brennan, A. Kahn, P. Spellman, R. Wilson, T. Speed, J. Gray, M. Meyerson, G. Getz, C. Perou, D. Hayes (2010)
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.Cancer cell, 17 1
T. Wilson, M. Karajannis, D. Harter (2014)
Glioblastoma multiforme: State of the art and future therapeuticsSurgical Neurology International, 5
Z Xing, X Yang, D She, Y Lin, Y Zhang, D Cao (2017)
Noninvasive assessment of IDH mutational status in World Health Organization grade II and III astrocytomas using DWI and DSC-PWI combined with conventional MR imagingAJNR Am J Neuroradiol, 38
P. Kickingereder, F. Sahm, A. Radbruch, W. Wick, S. Heiland, A. Deimling, M. Bendszus, B. Wiestler (2015)
IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human gliomaScientific Reports, 5
K. Aldape, P. Burger, A. Perry (2007)
Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma.Archives of pathology & laboratory medicine, 131 2
M. Sanson, Y. Marie, S. Paris, A. Idbaih, J. Laffaire, F. Ducray, S. Hallani, B. Boisselier, K. Mokhtari, K. Hoang-Xuan, J. Delattre (2009)
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 25
D. Reuss, F. Sahm, D. Schrimpf, B. Wiestler, D. Capper, C. Koelsche, L. Schweizer, A. Korshunov, David Jones, V. Hovestadt, M. Mittelbronn, J. Schittenhelm, C. Herold‐Mende, A. Unterberg, M. Platten, M. Weller, W. Wick, S. Pfister, A. Deimling (2014)
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastomaActa Neuropathologica, 129
P. Zinn, Zeeshan Mahmood, Mohamed Elbanan, R. Colen (2015)
Imaging Genomics in Gliomas.Cancer journal, 21 3
T. Wilson (2014)
Glioblastoma – A tale of two tumors: Case comparison and literature reviewSurgical Neurology International, 5
K Vigneswaran (2015)
95Ann Transl Med, 3
P. Metellus, B. Coulibaly, C. Colin, A. Paula, A. Vasiljevic, D. Taieb, A. Barlier, B. Boisselier, K. Mokhtari, Xiao Wang, A. Loundou, F. Chapon, S. Pineau, L. Ouafik, O. Chinot, D. Figarella-Branger (2010)
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosisActa Neuropathologica, 120
D. Parsons, Siân Jones, Xiaosong Zhang, Jimmy Lin, R. Leary, P. Angenendt, P. Mankoo, H. Carter, I. Siu, G. Gallia, A. Olivi, R. McLendon, B. Rasheed, S. Keir, T. Nikolskaya, Y. Nikolsky, D. Busam, H. Tekleab, L. Diaz, James Hartigan, Douglas Smith, R. Strausberg, S. Marie, S. Shinjo, Hai Yan, G. Riggins, D. Bigner, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V. Velculescu, K. Kinzler (2008)
An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 321
Kui Zhang, Xiao-qin Wang, Bin Zhou, Lin Zhang (2013)
The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysisFamilial Cancer, 12
W. Pope, Jenny Chen, Jun Dong, M. Carlson, A. Perlina, T. Cloughesy, L. Liau, P. Mischel, P. Nghiemphu, A. Lai, S. Nelson (2008)
Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis.Radiology, 249 1
Safwan Moton, Mohamed Elbanan, P. Zinn, R. Colen (2015)
Imaging Genomics of Glioblastoma: Biology, Biomarkers, and BreakthroughsTopics in Magnetic Resonance Imaging, 24
C. Koschmann, Anda-Alexandra Calinescu, Felipe Núñez, A. Mackay, Janet Fazal-Salom, Daniel Thomas, Flor Mendez, Neha Kamran, Marta Dzaman, Lakshman Mulpuri, Johnathon Krasinkiewicz, Robert Doherty, R. Lemons, J. Brosnan-Cashman, Youping Li, Soyeon Roh, Lili Zhao, H. Appelman, D. Ferguson, V. Gorbunova, A. Meeker, Chris Jones, P. Lowenstein, M. Castro (2016)
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in gliomaScience Translational Medicine, 8
M. Diehn, C. Nardini, David Wang, S. McGovern, M. Jayaraman, Yu Liang, K. Aldape, S. Cha, M. Kuo (2008)
Identification of noninvasive imaging surrogates for brain tumor gene-expression modulesProceedings of the National Academy of Sciences, 105
Kasthuri Kannan, A. Inagaki, J. Silber, D. Gorovets, Jianan Zhang, Edward Kastenhuber, A. Heguy, J. Petrini, T. Chan, J. Huse (2012)
Whole exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade gliomaOncotarget, 3
R. Stupp, M. Hegi, W. Mason, M. Bent, M. Taphoorn, R. Janzer, S. Ludwin, A. Allgeier, B. Fisher, K. Bélanger, P. Hau, A. Brandes, J. Gijtenbeek, C. Marosi, C. Vecht, K. Mokhtari, P. Wesseling, S. Villà, E. Eisenhauer, T. Gorlia, M. Weller, D. Lacombe, J. Cairncross, R. Mirimanoff (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.The Lancet. Oncology, 10 5
C Hill, SB Hunter, DJ Brat (2003)
Genetic markers in glioblastoma: prognostic significance and future therapeutic implicationsAdv Anat Pathol, 10
Objectives To assess the association between MR imaging features and major genomic profiles in glioblastoma. Methods Qualitative and quantitative imaging features such as volumetrics and histogram analysis from normalised CBV (nCBV) and ADC (nADC) were evaluated based on both T2WI and CET1WI. The imaging parameters of different genetic profile groups were compared and regression analyses were used for identifying imaging-molecular associations. Progression- free survival (PFS) was analysed by a Kaplan-Meier test and Cox proportional hazards model. Results An IDH mutation was observed in 18/176 patients, and ATRX loss was positive in 17/158 of the IDH-wt cases. The IDH-mut group showed a larger volume on T2WI and a higher volume ratio between T2WI and CET1WI than the IDH-wt group (p < 0.05). In the IDH-mut group, higher mean nADC values were observed compared with the IDH-wt tumours (p < 0.05). Among the IDH-wt tumours, IDH-wt, ATRX-loss tumours revealed higher 5th percentile nADC values than the IDH-wt, ATRX-noloss tumours (p= 0.03). PFS was the longest in the IDH-mut group, followed by the IDH-wt, ATRX-loss groups and the IDH-wt, ATRX-noloss groups, consecutively (p < 0.05). We found significant associations of PFS with the genetic profiles and imaging parameters. Conclusion Major genetic profiles
European Radiology – Springer Journals
Published: May 2, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.